Pfizer, Novartis agree UK price cuts for new breast cancer drugs Ruby Khatun Khatun17 Nov 2017 9:45 AM ISTLONDON: Pfizer and Novartis have agreed to price cuts for their rival breast cancer drugs Ibrance and Kisqali to ensure they can be used routinely...
USFDA lifts import alert on Divis Labs Vizag unit Ruby Khatun Khatun16 Nov 2017 11:01 AM ISTNew Delhi: Drug firm Divis Laboratories on Wednesday said the US health regulator has lifted import alert imposed on its unit at Visakhapatnam.Last...
Sun Pharma Q2 net profit dives 59 percent at Rs 912.12 crore Ruby Khatun Khatun16 Nov 2017 10:15 AM ISTNew Delhi: Pharma major Sun Pharmaceutical Industries reported a 59.19 percent dip in consolidated net profit to Rs 912.12 crore for the quarter ended...
DRL launches anti-cancer drug in US market Ruby Khatun Khatun16 Nov 2017 10:01 AM ISTNew Delhi: Dr. Reddy's Laboratories Ltd (DRL) announced that it has launched Clofarabine Injection, a therapeutic equivalent generic version of Clolar...
AstraZeneca gets FDA approval for asthma drug Ruby Khatun Khatun16 Nov 2017 10:00 AM ISTAstraZeneca and its global biologics research and development arm, MedImmune, announced that the US Food and Drug Administration (FDA) has approved...
Cost of diabetes epidemic reaches 850 billion dollars a year Ruby Khatun Khatun16 Nov 2017 9:32 AM ISTThe number of people living with diabetes has tripled since 2000, pushing the global cost of the disease to $850 billion a year, medical experts said...
Janssen drops US lawsuit against Samsung Bioepis Remicade copy Ruby Khatun Khatun16 Nov 2017 9:15 AM ISTSEOUL: A unit of healthcare conglomerate Johnson & Johnson has dropped a lawsuit it filed to block a copy of its rheumatoid arthritis drug...
FDA approves first drug in US with digital ingestion tracking Ruby Khatun Khatun15 Nov 2017 10:45 AM ISTThe U.S. Food and Drug Administration (FDA) approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole...
Cadila Healthcare Q2 net profit up 32 percent at Rs 503 crore Ruby Khatun Khatun15 Nov 2017 10:00 AM ISTNew Delhi: Drug firm Cadila Healthcare reported a 32.48 percent rise in its consolidated net profit to Rs 503.3 crore for the second quarter ended...
Novartis launches heart drug counter-offensive Ruby Khatun Khatun15 Nov 2017 9:45 AM ISTZURICH: Novartis plans to plow through doubts over its canakinumab drug by asking regulators this year to approve the medicine as a treatment for a...
Abbott India Q2 profit rises 83 percent to Rs 137.52 crore Ruby Khatun Khatun14 Nov 2017 10:23 AM ISTNew Delhi: Drug firm Abbott India reported 83.31% jump in net profit to Rs137.52 crore for the September quarter on account of robust sales.It had...
Morepen Labs reports 24 percent jump in its Q2 net profit Ruby Khatun Khatun14 Nov 2017 10:16 AM ISTNew Delhi: Morepen Laboratories Ltd. has reported a stable set of numbers in the second quarter (Q2) of fiscal 2017-18. The company has registered a...
